nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—ABCB1—adrenal gland cancer	0.973	1	CbGaD
Azelastine—CYP2C19—urine—adrenal gland cancer	0.000766	0.15	CbGeAlD
Azelastine—CYP1A2—urine—adrenal gland cancer	0.000626	0.123	CbGeAlD
Azelastine—CYP2C9—urine—adrenal gland cancer	0.000594	0.117	CbGeAlD
Azelastine—CYP2E1—urine—adrenal gland cancer	0.000563	0.111	CbGeAlD
Azelastine—CYP3A4—urine—adrenal gland cancer	0.000453	0.0889	CbGeAlD
Azelastine—CYP2D6—urine—adrenal gland cancer	0.000446	0.0875	CbGeAlD
Azelastine—KCNH2—cardiac atrium—adrenal gland cancer	0.00016	0.0315	CbGeAlD
Azelastine—CYP2B6—adrenal cortex—adrenal gland cancer	0.000159	0.0312	CbGeAlD
Azelastine—KCNH2—pituitary gland—adrenal gland cancer	0.000156	0.0307	CbGeAlD
Azelastine—CYP2C8—pituitary gland—adrenal gland cancer	0.000143	0.0281	CbGeAlD
Azelastine—KCNH2—adrenal gland—adrenal gland cancer	0.00014	0.0274	CbGeAlD
Azelastine—CYP1A1—cardiac atrium—adrenal gland cancer	0.000135	0.0266	CbGeAlD
Azelastine—CYP2B6—gonad—adrenal gland cancer	0.000132	0.0258	CbGeAlD
Azelastine—CYP2B6—adrenal gland—adrenal gland cancer	0.000115	0.0225	CbGeAlD
Azelastine—HRH1—adrenal gland—adrenal gland cancer	0.000112	0.022	CbGeAlD
Azelastine—CYP2E1—adrenal gland—adrenal gland cancer	0.000108	0.0211	CbGeAlD
Azelastine—ABCB1—adrenal cortex—adrenal gland cancer	8.49e-05	0.0167	CbGeAlD
Azelastine—ABCB1—gonad—adrenal gland cancer	7.04e-05	0.0138	CbGeAlD
Azelastine—ABCB1—pituitary gland—adrenal gland cancer	6.86e-05	0.0135	CbGeAlD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	6.4e-05	0.0029	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—TSHR—adrenal gland cancer	6.38e-05	0.0029	CbGpPWpGaD
Azelastine—HRH3—GPCR downstream signaling—GNAS—adrenal gland cancer	6.35e-05	0.00288	CbGpPWpGaD
Azelastine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	6.2e-05	0.00281	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—GNRHR—adrenal gland cancer	6.14e-05	0.00278	CbGpPWpGaD
Azelastine—ABCB1—adrenal gland—adrenal gland cancer	6.13e-05	0.012	CbGeAlD
Azelastine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	6.11e-05	0.00277	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—CDC42—adrenal gland cancer	6.04e-05	0.00274	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—SPRY2—adrenal gland cancer	6.01e-05	0.00273	CbGpPWpGaD
Azelastine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	5.93e-05	0.00269	CbGpPWpGaD
Azelastine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	5.88e-05	0.00267	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—TSHR—adrenal gland cancer	5.86e-05	0.00266	CbGpPWpGaD
Azelastine—ADRA1B—AMPK Signaling—TP53—adrenal gland cancer	5.77e-05	0.00262	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—GNAS—adrenal gland cancer	5.77e-05	0.00262	CbGpPWpGaD
Azelastine—CYP1A2—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	5.72e-05	0.00259	CbGpPWpGaD
Azelastine—CYP2A6—Biological oxidations—POMC—adrenal gland cancer	5.62e-05	0.00255	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—MEN1—adrenal gland cancer	5.51e-05	0.0025	CbGpPWpGaD
Azelastine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	5.02e-05	0.00228	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—SDHB—adrenal gland cancer	5.02e-05	0.00228	CbGpPWpGaD
Azelastine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	4.78e-05	0.00217	CbGpPWpGaD
Azelastine—CYP2B6—Biological oxidations—POMC—adrenal gland cancer	4.53e-05	0.00206	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—GNRH1—adrenal gland cancer	4.47e-05	0.00203	CbGpPWpGaD
Azelastine—CYP2E1—Biological oxidations—POMC—adrenal gland cancer	4.44e-05	0.00201	CbGpPWpGaD
Azelastine—CYP3A5—Biological oxidations—POMC—adrenal gland cancer	4.43e-05	0.00201	CbGpPWpGaD
Azelastine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	4.33e-05	0.00197	CbGpPWpGaD
Azelastine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	4.33e-05	0.00197	CbGpPWpGaD
Azelastine—HRH3—GPCR downstream signaling—POMC—adrenal gland cancer	4.28e-05	0.00194	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—PRKACA—adrenal gland cancer	4.2e-05	0.00191	CbGpPWpGaD
Azelastine—CYP1A1—Biological oxidations—POMC—adrenal gland cancer	4.18e-05	0.0019	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—GNAS—adrenal gland cancer	4.1e-05	0.00186	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—GNRH1—adrenal gland cancer	4.06e-05	0.00184	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—SDHB—adrenal gland cancer	4.05e-05	0.00184	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—GNRH1—adrenal gland cancer	4.05e-05	0.00184	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	4.04e-05	0.00183	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—GNRHR—adrenal gland cancer	4e-05	0.00182	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—TSHR—adrenal gland cancer	3.99e-05	0.00181	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—SDHB—adrenal gland cancer	3.97e-05	0.0018	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—SDHB—adrenal gland cancer	3.96e-05	0.0018	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—POMC—adrenal gland cancer	3.88e-05	0.00176	CbGpPWpGaD
Azelastine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	3.88e-05	0.00176	CbGpPWpGaD
Azelastine—CYP2C8—Biological oxidations—POMC—adrenal gland cancer	3.84e-05	0.00174	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—SDHB—adrenal gland cancer	3.74e-05	0.0017	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—SH3KBP1—adrenal gland cancer	3.72e-05	0.00169	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—GNAS—adrenal gland cancer	3.71e-05	0.00168	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	3.7e-05	0.00168	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—GNRH1—adrenal gland cancer	3.68e-05	0.00167	CbGpPWpGaD
Azelastine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	3.63e-05	0.00165	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—GNRHR—adrenal gland cancer	3.62e-05	0.00164	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—TSHR—adrenal gland cancer	3.62e-05	0.00164	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—TSHR—adrenal gland cancer	3.61e-05	0.00164	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—CDC42—adrenal gland cancer	3.57e-05	0.00162	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—ZNRF3—adrenal gland cancer	3.5e-05	0.00159	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—IGF2—adrenal gland cancer	3.44e-05	0.00156	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—SDHB—adrenal gland cancer	3.43e-05	0.00156	CbGpPWpGaD
Azelastine—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	3.42e-05	0.00155	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—GNAS—adrenal gland cancer	3.41e-05	0.00155	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—SH3KBP1—adrenal gland cancer	3.37e-05	0.00153	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	3.33e-05	0.00151	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—IGF1R—adrenal gland cancer	3.32e-05	0.00151	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	3.3e-05	0.0015	CbGpPWpGaD
Azelastine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	3.28e-05	0.00149	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—TSHR—adrenal gland cancer	3.28e-05	0.00149	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—RRM1—adrenal gland cancer	3.24e-05	0.00147	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—SDHD—adrenal gland cancer	3.24e-05	0.00147	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—ZNRF3—adrenal gland cancer	3.17e-05	0.00144	CbGpPWpGaD
Azelastine—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	3.15e-05	0.00143	CbGpPWpGaD
Azelastine—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	3.12e-05	0.00142	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—SDHB—adrenal gland cancer	3.06e-05	0.00139	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	3.01e-05	0.00137	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—SDHB—adrenal gland cancer	2.99e-05	0.00136	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	2.94e-05	0.00134	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—TERT—adrenal gland cancer	2.86e-05	0.0013	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—SDHB—adrenal gland cancer	2.82e-05	0.00128	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—SDHB—adrenal gland cancer	2.79e-05	0.00127	CbGpPWpGaD
Azelastine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	2.77e-05	0.00126	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—POMC—adrenal gland cancer	2.76e-05	0.00125	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	2.7e-05	0.00122	CbGpPWpGaD
Azelastine—CYP1A2—Biological oxidations—POMC—adrenal gland cancer	2.67e-05	0.00121	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—RRM1—adrenal gland cancer	2.61e-05	0.00118	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—SDHD—adrenal gland cancer	2.61e-05	0.00118	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—PRKACA—adrenal gland cancer	2.6e-05	0.00118	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	2.57e-05	0.00117	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—RRM1—adrenal gland cancer	2.56e-05	0.00116	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—SDHD—adrenal gland cancer	2.56e-05	0.00116	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—SDHD—adrenal gland cancer	2.55e-05	0.00116	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—RRM1—adrenal gland cancer	2.55e-05	0.00116	CbGpPWpGaD
Azelastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	2.51e-05	0.00114	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—POMC—adrenal gland cancer	2.5e-05	0.00113	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—BAD—adrenal gland cancer	2.49e-05	0.00113	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	2.45e-05	0.00111	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—CDC42—adrenal gland cancer	2.43e-05	0.0011	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—MED12—adrenal gland cancer	2.41e-05	0.00109	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—SDHD—adrenal gland cancer	2.41e-05	0.00109	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—RRM1—adrenal gland cancer	2.41e-05	0.00109	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	2.41e-05	0.00109	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—GNRH1—adrenal gland cancer	2.4e-05	0.00109	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—SDHB—adrenal gland cancer	2.39e-05	0.00108	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—PRKACA—adrenal gland cancer	2.35e-05	0.00107	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—GNAS—adrenal gland cancer	2.32e-05	0.00105	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—POMC—adrenal gland cancer	2.29e-05	0.00104	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—BRAF—adrenal gland cancer	2.27e-05	0.00103	CbGpPWpGaD
Azelastine—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	2.24e-05	0.00101	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—SDHD—adrenal gland cancer	2.21e-05	0.001	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—RRM1—adrenal gland cancer	2.21e-05	0.001	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—CDC42—adrenal gland cancer	2.2e-05	0.001	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	2.2e-05	0.000997	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—CDC42—adrenal gland cancer	2.2e-05	0.000996	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—EGFR—adrenal gland cancer	2.2e-05	0.000996	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—SPRY2—adrenal gland cancer	2.19e-05	0.000995	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	2.19e-05	0.000995	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—GNRH1—adrenal gland cancer	2.17e-05	0.000985	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—TSHR—adrenal gland cancer	2.14e-05	0.00097	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—GNAS—adrenal gland cancer	2.11e-05	0.000955	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—GNAS—adrenal gland cancer	2.1e-05	0.000952	CbGpPWpGaD
Azelastine—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	2.06e-05	0.000934	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MEN1—adrenal gland cancer	2.01e-05	0.000912	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—CDC42—adrenal gland cancer	1.99e-05	0.000905	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—SPRY2—adrenal gland cancer	1.99e-05	0.000901	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—SDHD—adrenal gland cancer	1.97e-05	0.000895	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—RRM1—adrenal gland cancer	1.97e-05	0.000895	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—MED12—adrenal gland cancer	1.95e-05	0.000883	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TSHR—adrenal gland cancer	1.94e-05	0.000878	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—RRM1—adrenal gland cancer	1.93e-05	0.000873	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—SDHD—adrenal gland cancer	1.93e-05	0.000873	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—MED12—adrenal gland cancer	1.91e-05	0.000865	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—GNAS—adrenal gland cancer	1.91e-05	0.000865	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—MED12—adrenal gland cancer	1.9e-05	0.000863	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	1.88e-05	0.000852	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—SDHB—adrenal gland cancer	1.84e-05	0.000835	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MEN1—adrenal gland cancer	1.82e-05	0.000825	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—RRM1—adrenal gland cancer	1.81e-05	0.000823	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—SDHD—adrenal gland cancer	1.81e-05	0.000823	CbGpPWpGaD
Azelastine—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	1.81e-05	0.000822	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—SDHD—adrenal gland cancer	1.8e-05	0.000816	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—RRM1—adrenal gland cancer	1.8e-05	0.000816	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—MED12—adrenal gland cancer	1.8e-05	0.000815	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PRKACA—adrenal gland cancer	1.76e-05	0.000798	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	1.74e-05	0.000788	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—MED12—adrenal gland cancer	1.65e-05	0.000748	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—CTNNB1—adrenal gland cancer	1.64e-05	0.000743	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.61e-05	0.000729	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—POMC—adrenal gland cancer	1.56e-05	0.000708	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—RRM1—adrenal gland cancer	1.54e-05	0.000697	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—SDHD—adrenal gland cancer	1.54e-05	0.000697	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PRKACA—adrenal gland cancer	1.53e-05	0.000696	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.47e-05	0.000668	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—MED12—adrenal gland cancer	1.47e-05	0.000667	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	1.46e-05	0.000662	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—MED12—adrenal gland cancer	1.44e-05	0.000651	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—GNAS—adrenal gland cancer	1.43e-05	0.000647	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PRKACA—adrenal gland cancer	1.42e-05	0.000644	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—POMC—adrenal gland cancer	1.42e-05	0.000643	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—POMC—adrenal gland cancer	1.41e-05	0.000641	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—ABCB1—adrenal gland cancer	1.4e-05	0.000635	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PRKACA—adrenal gland cancer	1.39e-05	0.000631	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PRKACA—adrenal gland cancer	1.39e-05	0.00063	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	1.39e-05	0.00063	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—MED12—adrenal gland cancer	1.35e-05	0.000614	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—MED12—adrenal gland cancer	1.34e-05	0.000608	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.31e-05	0.000596	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PRKACA—adrenal gland cancer	1.31e-05	0.000595	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CDC42—adrenal gland cancer	1.3e-05	0.00059	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—EGFR—adrenal gland cancer	1.3e-05	0.000589	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—POMC—adrenal gland cancer	1.28e-05	0.000582	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.28e-05	0.000581	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IGF2—adrenal gland cancer	1.25e-05	0.000569	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—GNAS—adrenal gland cancer	1.24e-05	0.000564	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IGF1R—adrenal gland cancer	1.21e-05	0.00055	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PRKACA—adrenal gland cancer	1.2e-05	0.000545	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.2e-05	0.000544	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—SDHD—adrenal gland cancer	1.19e-05	0.000538	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—RRM1—adrenal gland cancer	1.19e-05	0.000538	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CDC42—adrenal gland cancer	1.18e-05	0.000534	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.17e-05	0.000533	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—GNAS—adrenal gland cancer	1.15e-05	0.000522	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—MED12—adrenal gland cancer	1.15e-05	0.00052	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IGF2—adrenal gland cancer	1.14e-05	0.000515	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—ABCB1—adrenal gland cancer	1.13e-05	0.000512	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—GNAS—adrenal gland cancer	1.13e-05	0.000511	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—GNAS—adrenal gland cancer	1.13e-05	0.000511	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—GNAS—adrenal gland cancer	1.12e-05	0.00051	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—ABCB1—adrenal gland cancer	1.11e-05	0.000502	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	1.1e-05	0.000501	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IGF1R—adrenal gland cancer	1.1e-05	0.000498	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—TP53—adrenal gland cancer	1.09e-05	0.000494	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	1.07e-05	0.000487	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—GNAS—adrenal gland cancer	1.06e-05	0.000482	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.05e-05	0.000476	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PRKACA—adrenal gland cancer	1.05e-05	0.000475	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—TERT—adrenal gland cancer	1.04e-05	0.000474	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—ABCB1—adrenal gland cancer	1.04e-05	0.000473	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.02e-05	0.000465	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	9.87e-06	0.000448	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	9.78e-06	0.000444	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—GNAS—adrenal gland cancer	9.74e-06	0.000442	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—POMC—adrenal gland cancer	9.6e-06	0.000436	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	9.56e-06	0.000434	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—ABCB1—adrenal gland cancer	9.56e-06	0.000434	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TERT—adrenal gland cancer	9.45e-06	0.000429	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—BAD—adrenal gland cancer	9.08e-06	0.000412	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—MED12—adrenal gland cancer	8.84e-06	0.000401	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—GNAS—adrenal gland cancer	8.7e-06	0.000395	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	8.53e-06	0.000387	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—GNAS—adrenal gland cancer	8.49e-06	0.000385	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—POMC—adrenal gland cancer	8.37e-06	0.00038	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	8.36e-06	0.000379	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—BRAF—adrenal gland cancer	8.27e-06	0.000375	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—BAD—adrenal gland cancer	8.22e-06	0.000373	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	8.17e-06	0.000371	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—EGFR—adrenal gland cancer	8.01e-06	0.000364	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—GNAS—adrenal gland cancer	8e-06	0.000363	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—GNAS—adrenal gland cancer	7.93e-06	0.00036	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	7.85e-06	0.000356	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	7.78e-06	0.000353	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—POMC—adrenal gland cancer	7.75e-06	0.000352	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PTGS2—adrenal gland cancer	7.66e-06	0.000348	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—POMC—adrenal gland cancer	7.59e-06	0.000344	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—POMC—adrenal gland cancer	7.58e-06	0.000344	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—POMC—adrenal gland cancer	7.57e-06	0.000344	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—BRAF—adrenal gland cancer	7.48e-06	0.00034	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—EGFR—adrenal gland cancer	7.25e-06	0.000329	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—POMC—adrenal gland cancer	7.16e-06	0.000325	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GNAS—adrenal gland cancer	6.78e-06	0.000307	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	6.65e-06	0.000302	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—POMC—adrenal gland cancer	6.56e-06	0.000298	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	6.45e-06	0.000293	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PTGS2—adrenal gland cancer	6.18e-06	0.00028	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PTGS2—adrenal gland cancer	6.05e-06	0.000275	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	6.04e-06	0.000274	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CTNNB1—adrenal gland cancer	5.98e-06	0.000271	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—POMC—adrenal gland cancer	5.86e-06	0.000266	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—POMC—adrenal gland cancer	5.71e-06	0.000259	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PTGS2—adrenal gland cancer	5.71e-06	0.000259	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CTNNB1—adrenal gland cancer	5.41e-06	0.000245	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—POMC—adrenal gland cancer	5.39e-06	0.000244	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—POMC—adrenal gland cancer	5.34e-06	0.000242	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PTGS2—adrenal gland cancer	5.23e-06	0.000237	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GNAS—adrenal gland cancer	5.23e-06	0.000237	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	5.13e-06	0.000233	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—EGFR—adrenal gland cancer	4.73e-06	0.000215	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	4.67e-06	0.000212	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—POMC—adrenal gland cancer	4.56e-06	0.000207	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PTGS2—adrenal gland cancer	4.56e-06	0.000207	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	4.3e-06	0.000195	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—EGFR—adrenal gland cancer	4.29e-06	0.000194	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	4.26e-06	0.000193	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—TP53—adrenal gland cancer	3.98e-06	0.00018	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	3.64e-06	0.000165	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TP53—adrenal gland cancer	3.6e-06	0.000163	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—POMC—adrenal gland cancer	3.52e-06	0.00016	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	2.81e-06	0.000127	CbGpPWpGaD
